Dr Sunali Mehta

2026

Journal - Research Article

Wang, S., Shafaei Pishabad, Z., Sarkar, D., Arun Bhandarkar, A., Sarwar, M., Jeffs, A., Reid, G., Braithwaite, A., & Mehta, S. (2026). YBX1 expression marks proliferative tumour states with context-dependent genomic instability: A pan-cancer analysis. International Journal of Molecular Sciences, 27(10), 4340. doi: 10.3390/ijms27104340

2025

Journal - Research Article

Bhandarkar, A. A., Kelly-Foleni, N. E., Sarkar, D., Jeffs, A., Slatter, T., Braithwaite, A., & Mehta, S. (2025). TP53 splice mutations have tumour-independent effects on genomic stability and prognosis: An in silico study. International Journal of Molecular Sciences, 26, 12080. doi: 10.3390/ijms262412080

Polwatta Lekamlage, S., Boix De Jesus, A. N., Machado Saraiva, A., Drummond, C., Dolan, H., March de Ribot, F., Royds, J. A., Mehta, S., Braithwaite, A. W., Hung, N. A., & Slatter, T. L. (2025). Δ133p53 isoform enhances TLR4 function to promote tumour growth. Carcinogenesis, 46(4), bgaf051. doi: 10.1093/carcin/bgaf051

Nezbedová, L., McGhie, T., Mehta, S., Christensen, M., Ahmed Nasef, N., & Heyes, J. (2025). Using the orchard-to-fork approach in designing nutritional trials: The apple phenolics case. Analytical Methods. Advance online publication. doi: 10.1039/d4ay02017k

Conference Contribution - Published proceedings: Abstract

Bhandarkar, A. A., Sarkar, D., Jeffs, A., Kelly-Foleni, N. E., Braithwaite, A., Slatter, T., & Mehta, S. (2025). Role of the TP53 splice mutations in cancer progression. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go

Shafaei Pishabad, Z., Sarkar, D., Jeffs, A., Samaratunga, H., Rhodes, J., Costello, R., Highton, A., Wright, D., Pattison, S., Kemp, R., Delahunt, B., Braithwaite, A., Slatter, T., & Mehta, S. (2025). Development of a prognostic tool for identifying high-risk prostate cancer patients. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go

2024

Journal - Research Other

Ray Das, S., Delahunt, B., Lasham, A., Li, K., Wright, D., Print, C., Slatter, T., Braithwaite, A., & Mehta, S. (2024). Combining TP53 mutation and isoform has the potential to improve clinical practice. Pathology, 56(4), 473-483. doi: 10.1016/j.pathol.2024.02.003

Conference Contribution - Verbal presentation and other Conference outputs

Sarkar, D., Gyanwali, G., Li, K., Sarwar, M., Braithwaite, A., & Mehta, S. (2024, August-September). Can YB-1 expression levels be used to classify immunotherapy responses of chromosomal instable tumours based on cGAS-STING activity? Verbal presentation at the Queenstown Research Week (QRW) Cancer Meeting, Queenstown, New Zealand.

Shevchuk, P., Sarkar, D., Gyanwali, G., Tsai, P., & Mehta, S. (2024, August-September). Characterising the biology of missense C176 mutation in tumour suppressor p53. Verbal presentation at the Queenstown Research Week (QRW) Cancer Meeting, Queenstown, New Zealand.

Sarkar, D., Gyanwali, G. C., Patel, J., Shevchuk, P., Woolley, A., Siddiqui, H., Ratajska, M., Sarwar, M., Drummond, C. J., McKinney, C., Antony, J., McCormick, S. P., Braithwaite, A., & Mehta, S. (2024, August-September). Role of H179 p53 mutation in driving aggressive tumours in patients. Verbal presentation at the Queenstown Research Week (QRW) Cancer Meeting, Queenstown, New Zealand.

2023

Journal - Research Article

Wiles, A. K., Mehta, S., Millier, M., Woolley, A. G., Li, K., Parker, K., Kazantseva, M., Wilson, M., Young, K., Bowie, S., Ray, S., Slatter, T. L., Stamp, L. K., Hessian, P. A., & Braithwaite, A. W. (2023). Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis. Arthritis Research & Therapy, 25, 62. doi: 10.1186/s13075-023-03040-8

Boix De Jesus, A. N., Taha, A., Wang, D., Mehta, P. M., Mehta, S., Reily-Bell, A., Polwatta Lekamlage, S., Machado Saraiva, A., Tahmeedzaman, T., … Royds, J., Braithwaite, A., Hung, N., & Slatter, T. L. (2023). Increased expression of the Δ133p53ß isoform enhances brain metastasis. International Journal of Molecular Sciences, 24, 1267. doi: 10.3390/ijms24021267

Conference Contribution - Published proceedings: Abstract

Nezbedová, L., Heyes, J., Ahmed Nasef, N., & Mehta, S. (2023). Phytochemicals from Monty’s Surprise apple are absorbed in humans, increase plasma antioxidant response, and inhibit lung and breast cancer proliferation in vitro. Proceedings of the Annual Scientific Meeting of the New Zealand and Australian Nutrition Societies: Nutrition and Wellbeing in Oceania. (pp. 80). Retrieved from https://nsnzconference.org.nz/

Nezbedová, L., Mehta, S., McGhie, T., Christensen, M., Heyes, J., & Ahmed Nasef, N. (2023). Effects of Monty's Surprise apple consumption on acute antioxidant capacity and postprandial glucose. Proceedings of the New Zealand Institute of Food Science & Technology (NZIFST) Conference: Food in a Changing World. (pp. 29). Retrieved from https://nzifst.org.nz

Conference Contribution - Verbal presentation and other Conference outputs

Mehta, S. (2023, February). Determine the influence of X126 TP53 splice mutation on alteration in tumour-immune landscape, immunotherapy efficacy and patient prognosis. Verbal presentation at the Maurice Wilkins Centre (MWC) for Molecular Biodiversity Symposium, Dunedin, New Zealand.

2022

Journal - Research Article

Mehta, S., Wright, D., Black, M. A., Merrie, A., Anjomshoaa, A., Munro, F., Reeve, A., McCall, J., & Print, C. (2022). Impact of clinical data veracity on cancer genomic research. JNCI Cancer Spectrum. doi: 10.1093/jncics/pkac070

Shields, N. J., Peyroux, E. M., Campbell, K., Mehta, S., Woolley, A. G., Counoupas, C., Neumann, S., & Young, S. L. (2022). Calpains released from necrotic tumor cells enhance antigen cross-presentation to activate CD8⁺ T cells in vitro. Journal of Immunology, 209(9), 1635-1651. doi: 10.4049/jimmunol.2100500

Journal - Research Other

Li, K., Ly, K., Mehta, S., & Braithwaite, A. (2022). Importance of crosstalk between the microbiota and the neuroimmune system for tissue homeostasis. Clinical & Translational Immunology, 11, e1394. doi: 10.1002/cti2.1394

Conference Contribution - Published proceedings: Abstract

Henry, C., Paterson, E., Sarkar, D., Mehta, S., & Danielson, K. (2022). Investigating EV cargo in treatment resistant endometrial cancer. Proceedings of the ComBio Conference. (pp. 54). Retrieved from https://combio.org.au/combio2022/

Nezbedová, L., McGhie, T., Christensen, M., Heyes, J., Ahmed Nasef, N., & Mehta, S. (2022). Impact of processing on the phytochemical profile of NZ heritage apple cultivar 'Monty's Surprise' and their cancer management properties. Proceedings of the New Zealand Institute of Food Science & Technology (NZIFST) Conference: Collaboration: Building New Zealand Inc. S19. Retrieved from http://www.nzifst.org.nz

Conference Contribution - Verbal presentation and other Conference outputs

Polwatta, S. N., Boix De Jesús, A. N., Wang, D., Taha, A., Kazantseva, M., Zhou, J., Mehta, S., Saraiva, A. M., … Royds, J., … Braithwaite, A. W., Hung, N. A., & Slatter, T. L. (2022, August). The Δ 133p53 isoform enhances cell-surface trafficking to promote metastasis. Verbal presentation at the Cancer Satellite Meeting: Queenstown Research Week, Queenstown, New Zealand.

Other Research Output

Mehta, S. (2022, November). Cancer cell evolution: YB-1, chromosomal instability and uncharacterised TP53 mutations. UOC Research Seminar Series, University of Otago, Christchurch, New Zealand. [Research Presentation].

2021

Journal - Research Article

McDougall, L., Kueh, J. T. B., Ward, J., Tyndall, J. D. A., Woolley, A. G., Mehta, S., Stayner, C., Larsen, D. S., & Eccles, M. R. (2021). Chemical synthesis of the PAX protein inhibitor EG1 and its ability to slow the growth of human colorectal carcinoma cells. Frontiers in Oncology, 11, 709540. doi: 10.3389/fonc.2021.709540

Arsic, N., Slatter, T., Gadea, G., Villain, E., Fournet, A., Kazantseva, M., … Mehta, S., … Braithwaite, A., & Roux, P. (2021). Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells. Nature Communications, 12, 5463. doi: 10.1038/s41467-021-25550-2

Hong, C. R., Mehta, S. Y., Liyanage, H. D. S., McManaway, S. P., Lee, H. H., Jaiswal, J. K., … Hicks, K. O. (2021). Spatially-resolved pharmacokinetic/pharmacodynamic modelling of bystander effects of a nitrochloromethylbenzindoline hypoxia-activated prodrug. Cancer Chemotherapy & Pharmacology, 88, 673-687. doi: 10.1007/s00280-021-04320-3

Lasham, A., Knowlton, N., Mehta, S. Y., Braithwaite, A. W., & Print, C. G. (2021). Breast cancer patient prognosis is determined by the interplay between TP53 mutation and alternative transcript expression: Insights from TP53 long amplicon digital PCR assays. Cancers, 13(7), 1531. doi: 10.3390/cancers13071531

Ali, A., Mehta, S., Starck, C., Wong, M., O'Brien, W. J., Haswell, C., … Nasef, N. A. (2021). Effect of SunGold kiwifruit and vitamin C consumption on ameliorating exercise-induced stress response in women. Molecular Nutrition & Food Research, 65, 2001219. doi: 10.1002/mnfr.202001219

Journal - Research Other

Nezbedova, L., McGhie, T., Christensen, M., Heyes, J., Ahmed Nasef, N., & Mehta, S. (2021). Onco-preventive and chemo-protective effects of apple bioactive compounds. Nutrients, 13(11), 4025. doi: 10.3390/nu13114025

Mehta, S., Campbell, H., Drummond, C. J., Li, K., Murray, K., Slatter, T., … Braithwaite, A. W. (2021). Adaptive homeostasis and the p53 isoform network. EMBO Reports, 22, e53085. doi: 10.15252/embr.202153085

2020

Journal - Research Article

Weeks, R. J., Ludgate, J. L., Le Mée, G., Khanal, R., Mehta, S., Williams, G., Slatter, T. L., Braithwaite, A. W., & Morison, I. M. (2020). Silencing of Testin expression is a frequent event in spontaneous lymphomas from Trp53-mutant mice. Scientific Reports, 10, 16255. doi: 10.1038/s41598-020-73229-3

Mehta, S., Algie, M., Al-Jabry, T., McKinney, C., Kannan, S., Verma, C. S., … Parker, K., Henderson, L., Gould, M. L., Bhatia, P., Harfoot, R., … Kleffmann, T., … Woolley, A. G., … Braithwaite, A. (2020). Critical role for cold shock protein YB-1 in cytokinesis. Cancers, 12, 2473. doi: 10.3390/cancers12092473

Eiholzer, R. A., Mehta, S., Kazantseva, M., Drummond, C. J., McKinney, C., Young, K., … Fleming, N., Morrin, H. R., Reader, K., Royds, J. A., Landmann, M., Petrich, S., … Taha, A., Hung, N. A., Slatter, T. L., & Braithwaite, A. W. (2020). Intronic TP53 polymorphisms are associated with increased Δ133TP53 transcript, immune infiltration and cancer risk. Cancers, 12(9), 2472. doi: 10.3390/cancers12092472

Lasham, A., Tsai, P., Fitzgerald, S. J., Mehta, S. Y., Knowlton, N. S., Braithwaite, A. W., & Print, C. G. (2020). Accessing a new dimension in TP53 biology: Multiplex long amplicon digital PCR to specifically detect and quantitate individual TP53 transcripts. Cancers, 12(3), 769. doi: 10.3390/cancers12030769

Mehta, S., McKinney, C., Algie, M., Verma, C. S., Kannan, S., Harfoot, R., … Gould, M. L., Parker, K., … Cunliffe, H. E., … Kleffmann, T., Braithwaite, A. W., & Woolley, A. G. (2020). Dephosphorylation of YB-1 is required for nuclear localisation during G₂ phase of the cell cycle. Cancers, 12(2), 315. doi: 10.3390/cancers12020315

Lasham, A., Fitzgerald, S. J., Knowlton, N., Robb, T., Tsai, P., Black, M. A., … Mehta, S. Y., Harris, G., … Print, C. G. (2020). A predictor of early disease recurrence in patients with breast cancer using a cell-free RNA and protein liquid biopsy. Clinical Breast Cancer, 20(2), 108-116. doi: 10.1016/j.clbc.2019.07.003

Journal - Research Other

Ahmed Nasef, N., & Mehta, S. (2020). Role of inflammation in pathophysiology of colonic disease: An update. International Journal of Molecular Sciences, 21(13), 4748. doi: 10.3390/ijms21134748

2019

Journal - Research Article

Kazantseva, M., Mehta, S., Eiholzer, R. A., Gimenez, G., Bowie, S., Campbell, H., Reily-Bell, A. L., … Ray, S., Drummond, C. J., Reid, G., … Wiles, A., Morrin, H. R., Reader, K. L., Hung, N. A., Baird, M. A., Slatter, T. L., & Braithwaite, A. W. (2019). The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer. Cell Death & Disease, 10, 631. doi: 10.1038/s41419-019-1861-1

Conference Contribution - Published proceedings: Full paper

Johnson, T. G., Schelch, K., Mehta, S., Burgess, A., & Reid, G. (2019). Why be one protein when you can affect many? The multiple roles of YB-1 in lung cancer and mesothelioma. Frontiers in Cell & Developmental Biology, 7, 221. doi: 10.3389/fcell.2019.00221

2018

Journal - Research Article

Mehta, S. Y., Morten, B. C., Antony, J., Henderson, L., Lasham, A., Campbell, H., Cunliffe, H., Horsfield, J. A., … Braithwaite, A. W. (2018). Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes. Oncotarget, 9(49), 29146-29161. doi: 10.18632/oncotarget.25635

Kazantseva, M., Mehta, S., Eiholzer, R. A., Hung, N., Wiles, A., Slatter, T. L., & Braithwaite, A. W. (2018). A mouse model of the Δ133p53 isoform: Roles in cancer progression and inflammation. Mammalian Genome, 29, 831-842. doi: 10.1007/s00335-018-9758-3

Kazantseva, M., Eiholzer, R. A., Mehta, S., Taha, A., Bowie, S., Roth, I., Zhou, J., … Royds, J. A., Hung, N. A., Slatter, T. L., & Braithwaite, A. W. (2018). Elevation of the TP53 isoform Δ133p53β in glioblastomas: An alternative to mutant p53 in promoting tumour development. Journal of Pathology, 246(1), 77-88. doi: 10.1002/path.5111

Campbell, H., Fleming, N., Roth, I., Mehta, S., Wiles, A., Williams, G., … Munro, F., McNoe, L., Black, M., McCall, J., Slatter, T. L., … Braithwaite, A. W. (2018). Δ133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling. Nature Communications, 9(1), 254. doi: 10.1038/s41467-017-02408-0

Conference Contribution - Poster Presentation (not in published proceedings)

Eiholzer, R. A., Kazantseva, M., Mehta, S., Roth, I., Taha, A., Hung, N. A., Slatter, T. L., & Braithwaite, A. W. (2018, August). The role of the p53 isoform Δ133TPP53 in treatment resistance. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Ray, S., McKinney, C., Roth, L., Heinzel, S., Hodgkin, P., Mehta, S., Slatter, T. L., & Braithwaite, A. W. (2018, August). p53 does not cause growth arrest or death in normal B cells but only affects division rate. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Mehta, S., Algie, M., Al Jabri, T., McKinney, C., Verma, C., Weini, M., … Henderson, L., Gould, M., Parker, K., Bhatia, P., Harfoot, R., Kleffmann, T., … Woolley, A., & Braithwaite, A. (2018, August). RSK mediated YB-1 phosphorylation: A key event required for completion of cytokinesis. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Slatter, T. L., Kazantseva, M., Eiholzer, R. A., Mehta, S., Taha, A., Bowie, S., … Royds, J. A., Zhou, J., Hung, N. A., & Braithwaite, A. W. (2018, August). The TP53 isoform Δ133p53β in glioblastoma development. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Henderson, L., Mehta, S., Fleming, N., Eccles, M., Chatterjee, A., Print, C., … Braithwaite, A. (2018, August). p63 promotes proliferation in melanoma cell lines via regulation of AQP3. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

2017

Journal - Research Article

Tercel, M., Lee, H. H., Mehta, S. Y., Tendoung, J.-J. Y., Bai, S. Y., Liyanage, H. D. S., & Pruijn, F. B. (2017). Influence of a basic side chain on the properties of hypoxia-selective nitro analogues of the duocarmycins: Demonstration of substantial anticancer activity in combination with irradiation or chemotherapy. Journal of Medicinal Chemistry, 60(13), 5834-5856. doi: 10.1021/acs.jmedchem.7b00563

Kazantseva, M., Hung, N. A., Mehta, S., Roth, I., Eiholzer, R., Rich, A. M., Seo, B., Baird, M. A., Braithwaite, A. W., & Slatter, T. L. (2017). Tumor protein 53 mutations are enriched in diffuse large B-cell lymphoma with irregular CD19 marker expression. Scientific Reports, 7, 1566. doi: 10.1038/s41598-017-01800-6

Journal - Research Other

Nasef, N. A., Mehta, S., & Ferguson, L. R. (2017). Susceptibility to chronic inflammation: An update. Archives of Toxicology, 9(3), 1131-1141. doi: 10.1007/s00204-016-1914-5

Conference Contribution - Published proceedings: Abstract

Slatter, T. L., Kazantseva, M., Eiholzer, R., Mehta, S., Wiles, A., Bowie, S., Zhou, J., … Wilson, B. K. J., … Frampton, C. M., … Royds, J. A., … Hung, N. A., & Braithwaite, A. W. (2017). Elevated Δ133p53β correlates with a high tumor-associated macrophage content in glioblastoma with a poor patient outcome. Proceedings of the 3rd International p53 Isoforms Conference. (pp. 37). Retrieved from http://www.uib.no/en/ccbio

Kazantseva, M., Mehta, S., Eiholzer, R. A., Roth, I., Bowie, S., Joruiz, S., Royds, J. A., Taha, A., Hung, N. A., Baird, M. A., Slatter, T. L., & Braithwaite, A. W. (2017). Elevated Δ133p53β in prostate tumours correlates with an immune suppressive signature and poorer outcome. Proceedings of the 3rd International p53 Isoforms Conference. (pp. 29). Retrieved from http://www.uib.no/en/ccbio

Hale, T. K., Solomon, R., Bond, S. D., Mehta, S., Braithwaite, A., Wheeler, D., & Fitzsimons, H. (2017). Untethering the genome: Loss of HP1α enhances malignant cell invasion. In A. Blackman, L. Gillman, C. Oliver & D. Dantzic (Eds.), Proceedings of the Inaugural New Zealand Breast Cancer Symposium (NZBCS): United for a Cure through Research. (pp. 40). Auckland, New Zealand: Auckland University of Technology. [Abstract]

2016

Journal - Research Article

Mehta, S., Tsai, P., Lasham, A., Campbell, H., Reddel, R., Braithwaite, A., & Print, C. (2016). A study of TP53 RNA splicing illustrates pitfalls of RNA-seq methodology. Cancer Research, 76(24), 7151-7159. doi: 10.1158/0008-5472.can-16-1624

Lasham, A., Mehta, S. Y., Fitzgerald, S. J., Woolley, A. G., Hearn, J. I., Hurley, D. G., Ruza, I., Algie, M., … Braithwaite, A. W., & Print, C. G. (2016). A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line. International Journal of Cancer, 139(5), 1157-1170. doi: 10.1002/ijc.30137

Conference Contribution - Verbal presentation and other Conference outputs

Kazantseva, M., Hung, N., Mehta, S., Roth, I., Baird, M., Braithwaite, A., & Slatter, T. (2016, October). Mutant p53 promotes incorrect B cell differentiation and adverse outcome in DLBCL. Verbal presentation at the 7th International Mutant p53 Workshop, Melbourne, Australia.

Mehta, S., Lasham, A., Woolley, A., Algie, M., Al Jabry, T., Ma, W., Fleming, N., Young, K., Parker, K., … Braithwaite, A. (2016, August-September). Role of YB-1 in cell cycle. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.

Kazantseva, M., Hung, N., Mehta, S., Baird, M., Slatter, T., & Braithwaite, A. (2016, August-September). Investigating the association of Δ133p53 isoform expression and the inflammatory microenvironment in prostate tumours. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.

Campbell, H., Fleming, N., Roth, I., Vennin, C., McCall, J., Mehta, S., Wiles, A., Williams, G., … Baird, M., & Braithwaite, A. W. (2016, August-September). IL-6 signalling mediates tumorigenesis, invasion and metastasis driven by the Δ133p53 isoform. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Nelson, New Zealand.

2015

Journal - Research Article

Nasef, N. A., Mehta, S., Powell, P., Marlow, G., Wileman, T., & Ferguson, L. R. (2015). Extracts of feijoa inhibit toll-like receptor 2 signaling and activate autophagy implicating a role in dietary control of IBD. PLoS ONE, 10(6), e0130910. doi: 10.1371/journal.pone.0130910

2014

Journal - Research Article

Nasef, N. A., Mehta, S., & Ferguson, L. R. (2014). Dietary interventions with the bacterial sensing machinery in the intestine: The plant polyphenol case. Frontiers in Genetics, 5, 64. doi: 10.3389/fgene.2014.00064

Nasef, N. A., Mehta, S., Murray, P., Marlow, G., & Ferguson, L. R. (2014). Anti-inflammatory activity of fruit fractions in vitro, mediated through toll-like receptor 4 and 2 in the context of inflammatory bowel disease. Nutrients, 6(11), 5265-5279. doi: 10.3390/nu6115265

2013

Conference Contribution - Poster Presentation (not in published proceedings)

Mehta, S. (2013, August). Use of clinicopathological and oncogenic pathway signatures to improve clinical decisions for colorectal cancer patients. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Wright, D., Mehta, S., Munro, F., Merrie, A., Print, C., & McCall, J. (2013, August). Impact of inconsistencies in clinic-pathological data on molecular and survival analyses. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Awarded Doctoral Degree

Mehta, S. Y. (2013). Combining clinicopathological and molecular pathway signatures for improving clinical decisions through an understanding of colorectal cancer biology (PhD). University of Auckland, Auckland, New Zealand. Retrieved from http://hdl.handle.net/2292/20770

2012

Journal - Research Article

Richter, S., Richter, J. P., Mehta, S. Y., Gribble, A. M., Sutherland-Smith, A. J., Stowell, K. M., … Wilson, W. R. (2012). Expression and role in glycolysis of human ADP-dependent glucokinase. Molecular & Cellular Biochemistry, 364(1), 131-145. doi: 10.1007/s11010-011-1212-8

Conference Contribution - Verbal presentation and other Conference outputs

Mehta, S., Lasham, A., Wright, D., Black, M. A., Reeve, A., Guilford, P., McCall, J., … Print, C. (2012, August). Towards improving clinical decisions for colon cancer patients: A step closer to personalised medicine. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.